GUWAHATI: A potential COVID-19 vaccine, the first to be developed in India, has been given approval by DCGI (Drug Controller General of India) for Phase I and II human clinical trials.
Central Drugs Standard Control Organisation has granted approval to Bharat Biotech India to conduct human clinical trials for ‘Covaxin’ which is scheduled to start across India in July.
{{XNEQzJ3t7mkXDj6XAKuX}}
The permission was granted after the company submitted results from pre-clinical studies of the vaccine that demonstrated its safety and immune response, said Bharat Biotech in its release.
